How we use recombinant activated Factor VII in patients with haemophilia A or B complicated by inhibitors. Working group of hematology experts from Australia and New Zealand, Melbourne, April 2011.
about
Rapid rFVIIa enhanced on-demand dosing in haemophilia inhibitor patients.Spanish consensus guidelines on prophylaxis with bypassing agents for surgery in patients with haemophilia and inhibitors.Pulmonary embolus in a haemophilia patient.Combined administration of FVIII and rFVIIa improves haemostasis in haemophilia A patients with high-responding inhibitors--a thrombin generation-guided pilot study.Targeting Acquired Hemophilia A with Rheumatoid Arthritis by a Rituximab Shot: A Case Report and Review of the Literature.
P2860
How we use recombinant activated Factor VII in patients with haemophilia A or B complicated by inhibitors. Working group of hematology experts from Australia and New Zealand, Melbourne, April 2011.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
How we use recombinant activat ...... ealand, Melbourne, April 2011.
@en
type
label
How we use recombinant activat ...... ealand, Melbourne, April 2011.
@en
prefLabel
How we use recombinant activat ...... ealand, Melbourne, April 2011.
@en
P2093
P2860
P921
P1476
How we use recombinant activat ...... ealand, Melbourne, April 2011.
@en
P2093
Hematology working group
J Phillips
P Ockelford
P2860
P304
P356
10.1111/J.1445-5994.2012.02942.X
P577
2012-11-01T00:00:00Z